{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:46Z","timestamp":1761513406944},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T00:00:00Z","timestamp":1390521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s40618-014-0052-2","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T14:27:51Z","timestamp":1390487271000},"page":"393-400","source":"Crossref","is-referenced-by-count":18,"title":["Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism"],"prefix":"10.1007","volume":"37","author":[{"given":"G.","family":"Tirabassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"delli Muti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Balercia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,24]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06360.x","volume":"1260","author":"F Oury","year":"2012","unstructured":"Oury F (2012) A crosstalk between bone and gonads. Ann N Y Acad Sci 1260:1\u20137","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"52_CR2","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s11739-013-0914-1","volume":"8","author":"G Tirabassi","year":"2013","unstructured":"Tirabassi G, Gioia A, Giovannini L et al (2013) Testosterone and cardiovascular risk. Intern Emerg Med 8(Suppl 1):S65\u2013S69","journal-title":"Intern Emerg Med"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-11-0221","volume":"165","author":"F Saad","year":"2011","unstructured":"Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 165:675\u2013685","journal-title":"Eur J Endocrinol"},{"key":"52_CR4","first-page":"1966","volume":"84","author":"PJ Snyder","year":"1999","unstructured":"Snyder PJ, Peachey H, Hannoush P et al (1999) Effect of testosterone treatment on bone mineral density in men over 65\u00a0years of age. J Clin Endocrinol Metab 84:1966\u20131972","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13685538.2011.631230","volume":"15","author":"A Aversa","year":"2012","unstructured":"Aversa A, Bruzziches R, Francomano D et al (2012) Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36\u00a0months controlled study. Aging Male 15:96\u2013102","journal-title":"Aging Male"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2010.07.001","volume":"503","author":"V Carnevale","year":"2010","unstructured":"Carnevale V, Romagnoli E, Cipriani C et al (2010) Sex hormones and bone health in males. Arch Biochem Biophys 503:110\u2013117","journal-title":"Arch Biochem Biophys"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.steroids.2008.10.003","volume":"74","author":"BL Clarke","year":"2009","unstructured":"Clarke BL, Khosla S (2009) Androgens and bone. Steroids 74:296\u2013305","journal-title":"Steroids"},{"key":"52_CR8","doi-asserted-by":"crossref","unstructured":"Delli Muti N,\u00a0Agarwal A,\u00a0Buldreghini E,\u00a0et al (2013) Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? Andrologia. doi: 10.1111\/and.12119 . (Epub ahead of print)","DOI":"10.1111\/and.12119"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2605.2003.00393.x","volume":"26","author":"M Zitzmann","year":"2003","unstructured":"Zitzmann M, Nieschlag E (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26:76\u201383","journal-title":"Int J Androl"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2265.2001.01403.x","volume":"55","author":"I Pottelbergh Van","year":"2001","unstructured":"Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C, Kaufman JM (2001) Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf) 55:659\u2013666","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mpo.10342","volume":"41","author":"RC Olney","year":"2003","unstructured":"Olney RC (2003) Regulation of bone mass by growth hormone. Med Pediatr Oncol 41:228\u2013234","journal-title":"Med Pediatr Oncol"},{"key":"52_CR12","first-page":"380","volume":"60","author":"GR Williams","year":"2009","unstructured":"Williams GR (2009) Actions of thyroid hormones in bone. Endokrynol Pol. 60:380\u2013388","journal-title":"Endokrynol Pol."},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF03345431","volume":"35","author":"G Arnaldi","year":"2012","unstructured":"Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M (2012) Advances in the epidemiology, pathogenesis, and management of Cushing\u2019s syndrome complications. J Endocrinol Investig 35:434\u2013448","journal-title":"J Endocrinol Investig"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","volume":"95","author":"S Bhasin","year":"2010","unstructured":"Bhasin S, Cunningham GR, Hayes FJ et al (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:2536\u20132559","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1745-7262.2007.00275.x","volume":"9","author":"F Saad","year":"2007","unstructured":"Saad F, Kamischke A, Yassin A et al (2007) More than eight years\u2019 hands-on experience with the novel long-acting parenteral testosterone undecanoate. Asian J Androl 9:291\u2013297","journal-title":"Asian J Androl"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000318503","volume":"38","author":"E Gabellieri","year":"2010","unstructured":"Gabellieri E, Chiovato L, Lage M, Castro AI, Casanueva FF (2010) Testing growth hormone deficiency in adults. Front Horm Res 38:139\u2013144","journal-title":"Front Horm Res"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.2012-1616","volume":"97","author":"L Persani","year":"2012","unstructured":"Persani L (2012) Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 97:3068\u20133078","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1210\/jc.2010-0982","volume":"95","author":"AB Grossman","year":"2010","unstructured":"Grossman AB (2010) Clinical review: the diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 95:4855\u20134863","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR19","first-page":"503","volume":"82","author":"SS Rao","year":"2010","unstructured":"Rao SS, Budhwar N, Ashfaque A (2010) Osteoporosis in men. Am Fam Physician 82:503\u2013508","journal-title":"Am Fam Physician"},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2265.2001.01391.x","volume":"55","author":"M Zitzmann","year":"2001","unstructured":"Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55:649\u2013657","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1210\/jc.2004-1424","volume":"89","author":"M Zitzmann","year":"2004","unstructured":"Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E (2004) X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 89:6208\u20136217","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"52_CR22","doi-asserted-by":"crossref","first-page":"e11529","DOI":"10.1371\/journal.pone.0011529","volume":"5","author":"A Guadalupe-Grau","year":"2010","unstructured":"Guadalupe-Grau A, Rodr\u00edguez-Gonz\u00e1lez FG, Ponce-Gonz\u00e1lez JG et al (2010) Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS ONE 5(7):e11529. doi: 10.1371\/journal.pone.0011529","journal-title":"PLoS ONE"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/jme.0.0250085","volume":"25","author":"J Beilin","year":"2000","unstructured":"Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25:85\u201396","journal-title":"J Mol Endocrinol"},{"issue":"Suppl 1","key":"52_CR24","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1530\/EJE-09-0258","volume":"161","author":"JD Thomas","year":"2009","unstructured":"Thomas JD, Monson JP (2009) Adult GH deficiency throughout lifetime. Eur J Endocrinol 161(Suppl 1):S97\u2013S106","journal-title":"Eur J Endocrinol"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2265.2011.04096.x","volume":"75","author":"G Tirabassi","year":"2011","unstructured":"Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G (2011) Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state: a comparative study. Clin Endocrinol (Oxf) 75:666\u2013672","journal-title":"Clin Endocrinol (Oxf)"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/jc.2009-1146","volume":"95","author":"G Tirabassi","year":"2010","unstructured":"Tirabassi G, Faloia E, Papa R, Furlani G, Boscaro M, Arnaldi G (2010) Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing\u2019s disease. J Clin Endocrinol Metab 95:1115\u20131122","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-09-0125","volume":"160","author":"G Arnaldi","year":"2009","unstructured":"Arnaldi G, Tirabassi G, Papa R et al (2009) Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Eur J Endocrinol 160:891\u2013898","journal-title":"Eur J Endocrinol"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1743-6109.2012.02673.x","volume":"10","author":"A Granata","year":"2013","unstructured":"Granata A, Tirabassi G, Pugni V et al (2013) Sexual dysfunctions in men affected by autoimmune Addison\u2019s disease before and after short-term gluco- and mineralocorticoid replacement therapy. J Sex Med 10:2036\u20132043","journal-title":"J Sex Med"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","volume":"9","author":"M Andrioli","year":"2006","unstructured":"Andrioli M, Pecori Giraldi F, Cavagnini F (2006) Isolated corticotrophin deficiency. Pituitary 9:289\u2013295","journal-title":"Pituitary"},{"key":"52_CR30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","volume":"160","author":"K L\u00f8v\u00e5s","year":"2009","unstructured":"L\u00f8v\u00e5s K, Gjesdal CG, Christensen M et al (2009) Glucocorticoid replacement therapy and pharmacogenetics in Addison\u2019s disease: effects on bone. Eur J Endocrinol 160:993\u20131002","journal-title":"Eur J Endocrinol"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","volume":"120","author":"PM Zelissen","year":"1994","unstructured":"Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 120:207\u2013210","journal-title":"Ann Intern Med"},{"key":"52_CR32","first-page":"158484","volume":"2013","author":"M Nezzo","year":"2013","unstructured":"Nezzo M, De Visschere P, T\u2019sjoen G, Weyers S, Villeirs G (2013) Role of imaging in the diagnosis and management of complete androgen insensitivity syndrome in adults. Case Rep Radiol 2013:158484. doi: 10.1155\/2013\/158484","journal-title":"Case Rep Radiol"},{"key":"52_CR33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000023296","volume":"50","author":"S Bertelloni","year":"1998","unstructured":"Bertelloni S, Baroncelli GI, Federico G, Cappa M, Lala R, Saggese G (1998) Altered bone mineral density in patients with complete androgen insensitivity syndrome. Horm Res 50:309\u2013314","journal-title":"Horm Res"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1210\/jc.2005-2809","volume":"91","author":"V Sobel","year":"2006","unstructured":"Sobel V, Schwartz B, Zhu YS, Cordero JJ, Imperato-McGinley J (2006) Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. J Clin Endocrinol Metab 91:3017\u20133023","journal-title":"J Clin Endocrinol Metab"},{"key":"52_CR35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1561::AID-CNCR11>3.0.CO;2-Z","volume":"83","author":"T Diamond","year":"1998","unstructured":"Diamond T, Campbell J, Bryant C, Lynch W (1998) The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 83:1561\u20131566","journal-title":"Cancer"},{"key":"52_CR36","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/jsm.12268","volume":"10","author":"D Francomano","year":"2013","unstructured":"Francomano D, Greco EA, Lenzi A, Aversa A (2013) CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism? J Sex Med 10:2373\u20132381","journal-title":"J Sex Med"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00223-002-0019-8","volume":"73","author":"BL Langdahl","year":"2003","unstructured":"Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF (2003) A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 73:237\u2013243","journal-title":"Calcif Tissue Int"},{"key":"52_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S8756-3282(03)00032-2","volume":"32","author":"T Remes","year":"2003","unstructured":"Remes T, V\u00e4is\u00e4nen SB, Mahonen A et al (2003) Aerobic exercise and\u00a0bone\u00a0mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alpha gene polymorphisms small star, filled. Bone 32:412\u2013420","journal-title":"Bone"},{"key":"52_CR39","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-005-1889-1","volume":"16","author":"VV V\u00e4lim\u00e4ki","year":"2005","unstructured":"V\u00e4lim\u00e4ki VV, Piippo K, V\u00e4lim\u00e4ki S, L\u00f6yttyniemi E, Kontula K, V\u00e4lim\u00e4ki MJ (2005) The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. Osteoporos Int 16:1633\u20131640","journal-title":"Osteoporos Int"},{"key":"52_CR40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00223-008-9128-3","volume":"82","author":"F Stiger","year":"2008","unstructured":"Stiger F, Br\u00e4ndstr\u00f6m H, Gillberg P et al (2008) Association between repeat length of exon 1 CAG microsatellite in the androgen receptor and bone density in men is modulated by sex hormone levels. Calcif Tissue Int 82:427\u2013435","journal-title":"Calcif Tissue Int"},{"key":"52_CR41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2010-1878","volume":"96","author":"A Ferlin","year":"2011","unstructured":"Ferlin A, Schipilliti M, Vinanzi C et al (2011) Bone\u00a0mass\u00a0in\u00a0subjects\u00a0with\u00a0Klinefelter\u00a0syndrome:\u00a0role\u00a0of\u00a0testosterone\u00a0levels\u00a0and\u00a0androgen\u00a0receptor\u00a0gene\u00a0CAG polymorphism. J Clin Endocrinol Metab 96:739\u2013745","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0052-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0052-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0052-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T23:09:21Z","timestamp":1559516961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0052-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,24]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0052-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,24]]}}}